From
to ZETA
Manufacturing for Monoclonal Antibodies
ZETA delivers end-to-end, GMP-compliant solutions for scalable, high-yield mAb manufacturing.
Monoclonal antibodies (mAbs) are transforming medicine – and demand is rising.
Caption: Lorem ipsum dolor sit amet, consectetuer
Tackling the challenges of mAb manufacturing. Building achievements on strong foundations.
Downstream processing
Achieve high product purity with efficient chromatography and filtration strategies.
Regulatory compliance
Comply with evolving GMP standards for both clinical and commercial supply.
Scale-up
Ensure performance consistency across lab, pilot, and industrial-scale production.
Time
Accelerate time to clinic with high-titer cell lines.
Yield optimization
Achieving high yields while minimizing by-products.
Upstream, Harvest and Downstream Biopharma Production
Complex mAb Project realized efficiently.
Flexible multiproduct facility for monoclonal antibodies delivered on fast-track schedule. End-to-end upstream and downstream integration enables scalable CHO-based biomanufacturing with future-ready process adaptability.